IDH2 and central nervous system cancer: The isocitrate dehydrogenase (IDH) gene mutation is another major genetic modification in gliomas that is associated with an enhanced DNA hypermethylation profile; patients with mutated IDH1 and two gliomas have a better prognosis than patients with wild-type gliomas [41].